Beta Bionics, Inc.
BBNX
DELAYED 1 MONTH
26 insider filings · Latest: Jun 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Jun 5 10:05 PM | Mark HopmanChief Commercial Officer | Sale | 275 | $12.31 | $3.4K | 130,612(D) | View → |
| Jun 4, 2026 | Jun 5 10:05 PM | Christy JonesDirector | Sale | 2,811 | $14.00 | $39.4K | 27,400(D) | View → |
| Jun 2, 2026 | Jun 3 10:13 PM | Mike MensingerChief Product Officer | Sale | 4,378 | $12.61 | $55.2K | 184,415(D) | View → |
| Jun 2, 2026 | Jun 3 10:00 PM | Mark HopmanChief Commercial Officer | Sale | 5,329 | $12.61 | $67.2K | 130,887(D) | View → |
| Jun 2, 2026 | Jun 3 10:00 PM | Steven Jon RussellChief Medical Officer | Sale | 4,222 | $12.61 | $53.2K | 173,849(D) | View → |
| Jun 2, 2026 | Jun 3 10:00 PM | Stephen FeiderChief Financial Officer | Sale | 6,676 | $12.61 | $84.2K | 166,053(D) | View → |
| Jun 2, 2026 | Jun 3 10:00 PM | Sean SaintDirector, President & CEO | Sale | 16,872 | $12.61 | $212.7K | 420,937(D) | View → |
| May 21, 2026 | May 26 10:00 PM | Christy JonesDirector | Sale | 1,998 | $9.95 | $19.9K | 13,246(D) | View → |
| May 22, 2026 | May 26 10:00 PM | Adam LezackDirector | Sale | 998 | $11.21 | $11.2K | 27,399(D) | View → |
| May 21, 2026 | May 26 10:00 PM | Adam LezackDirector | Sale | 1,000 | $9.95 | $9.9K | 11,432(D) | View → |
| Dec 4, 2025 | Mar 16 11:55 PM | Mark HopmanChief Commercial Officer | Sale | 2,061 | $30.66 | $63.2K | 136,216(D) | View → |
| Dec 2, 2025 | Mar 16 11:55 PM | Mark HopmanChief Commercial Officer | Sale | 856 | $29.34 | $25.1K | 138,277(D) | View → |
| Dec 2, 2025 | Mar 16 11:55 PM | Steven Jon RussellChief Medical Officer | Sale | 1,025 | $29.34 | $30.1K | 178,071(D) | View → |
| Mar 4, 2026 | Mar 6 12:30 AM | Mark HopmanChief Commercial Officer | Sale | 353 | $11.57 | $4.1K | 139,133(D) | View → |
| Mar 2, 2026 | Mar 3 11:45 PM | Mark HopmanChief Commercial Officer | Sale | 834 | $12.36 | $10.3K | 139,486(D) | View → |
| Mar 2, 2026 | Mar 3 11:45 PM | Steven Jon RussellChief Medical Officer | Sale | 1,026 | $12.36 | $12.7K | 179,096(D) | View → |
| Mar 2, 2026 | Mar 3 11:45 PM | Mike MensingerChief Product Officer | Sale | 1,064 | $12.36 | $13.2K | 188,793(D) | View → |
| Mar 2, 2026 | Mar 3 11:45 PM | Stephen FeiderChief Financial Officer | Sale | 1,428 | $12.36 | $17.7K | 172,729(D) | View → |
| Mar 2, 2026 | Mar 3 11:45 PM | Sean SaintDirector, President & CEO | Sale | 3,384 | $12.36 | $41.8K | 437,809(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Mar 13 8:15 PM | Mike MensingerChief Product Officer | Grant/Award | 91,520 | $12.63 | 91,520(D) | View → |
| Feb 27, 2026 | Mar 13 8:15 PM | Steven Jon RussellChief Medical Officer | Grant/Award | 91,520 | $12.63 | 91,520(D) | View → |
| Feb 27, 2026 | Mar 13 8:15 PM | Sean SaintDirector, President & CEO | Grant/Award | 287,944 | $12.63 | 287,944(D) | View → |
| Feb 27, 2026 | Mar 13 8:15 PM | Mark HopmanChief Commercial Officer | Grant/Award | 91,520 | $12.63 | 91,520(D) | View → |
| Feb 27, 2026 | Mar 13 8:15 PM | Stephen FeiderChief Financial Officer | Grant/Award | 110,342 | $12.63 | 110,342(D) | View → |
| Feb 27, 2026 | Mar 3 11:45 PM | Mark HopmanChief Commercial Officer | Grant/Award | 58,749 | $12.63 | 58,749(D) | View → |
| Feb 27, 2026 | Mar 3 11:45 PM | Steven Jon RussellChief Medical Officer | Grant/Award | 58,749 | $12.63 | 58,749(D) | View → |
| Feb 27, 2026 | Mar 3 11:45 PM | Mike MensingerChief Product Officer | Grant/Award | 58,749 | $12.63 | 58,749(D) | View → |
| Feb 27, 2026 | Mar 3 11:45 PM | Stephen FeiderChief Financial Officer | Grant/Award | 70,831 | $12.63 | 70,831(D) | View → |
| Feb 27, 2026 | Mar 3 11:45 PM | Sean SaintDirector, President & CEO | Grant/Award | 184,837 | $12.63 | 184,837(D) | View → |